OxFORD Asset Management LLP Has $557,000 Holdings in Masimo Corporation (MASI)
OxFORD Asset Management LLP cut its stake in shares of Masimo Corporation (NASDAQ:MASI) by 88.3% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 6,109 shares of the medical equipment provider’s stock after selling 46,040 shares during the quarter. OxFORD Asset Management LLP’s holdings in Masimo Corporation were worth $557,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Hancock Holding Co. bought a new position in shares of Masimo Corporation during the second quarter valued at $1,196,000. Renaissance Technologies LLC lifted its holdings in shares of Masimo Corporation by 44.6% during the second quarter. Renaissance Technologies LLC now owns 620,500 shares of the medical equipment provider’s stock valued at $56,577,000 after acquiring an additional 191,400 shares during the period. Advisor Group Inc. lifted its holdings in shares of Masimo Corporation by 38.4% during the second quarter. Advisor Group Inc. now owns 2,361 shares of the medical equipment provider’s stock valued at $216,000 after acquiring an additional 655 shares during the period. Nordea Investment Management AB bought a new position in shares of Masimo Corporation during the second quarter valued at $1,806,000. Finally, Hanseatic Management Services Inc. lifted its holdings in shares of Masimo Corporation by 1.1% during the second quarter. Hanseatic Management Services Inc. now owns 5,273 shares of the medical equipment provider’s stock valued at $481,000 after acquiring an additional 58 shares during the period. 83.21% of the stock is owned by institutional investors.
In other Masimo Corporation news, Director Sanford Fitch sold 11,000 shares of the stock in a transaction dated Thursday, August 17th. The stock was sold at an average price of $87.25, for a total value of $959,750.00. Following the completion of the transaction, the director now directly owns 72,249 shares in the company, valued at $6,303,725.25. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Jon Coleman sold 25,000 shares of the stock in a transaction dated Thursday, July 20th. The shares were sold at an average price of $97.50, for a total value of $2,437,500.00. Following the completion of the transaction, the insider now owns 32,201 shares of the company’s stock, valued at $3,139,597.50. The disclosure for this sale can be found here. 16.60% of the stock is currently owned by company insiders.
A number of research firms recently issued reports on MASI. Roth Capital lifted their price target on Masimo Corporation from $96.00 to $105.00 and gave the company a “buy” rating in a report on Wednesday, July 19th. BidaskClub cut Masimo Corporation from a “buy” rating to a “hold” rating in a report on Monday, July 31st. Zacks Investment Research raised Masimo Corporation from a “sell” rating to a “hold” rating in a report on Tuesday, July 11th. Stifel Nicolaus began coverage on Masimo Corporation in a report on Monday, July 10th. They issued a “buy” rating and a $105.00 price target for the company. Finally, BTIG Research raised Masimo Corporation from a “neutral” rating to a “buy” rating and set a $100.00 price target for the company in a report on Monday, August 14th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and four have given a buy rating to the company. The company currently has an average rating of “Hold” and an average price target of $97.00.
Masimo Corporation (NASDAQ:MASI) opened at 85.50 on Wednesday. The company has a market capitalization of $4.44 billion, a PE ratio of 14.01 and a beta of 0.82. The company has a 50 day moving average price of $85.41 and a 200-day moving average price of $89.87. Masimo Corporation has a 12-month low of $53.78 and a 12-month high of $104.71.
Masimo Corporation (NASDAQ:MASI) last announced its quarterly earnings data on Wednesday, August 2nd. The medical equipment provider reported $0.83 earnings per share for the quarter, topping the consensus estimate of $0.71 by $0.12. Masimo Corporation had a return on equity of 23.45% and a net margin of 45.90%. The business had revenue of $192.90 million during the quarter, compared to the consensus estimate of $189.03 million. During the same period in the prior year, the company earned $0.57 EPS. Masimo Corporation’s revenue for the quarter was up 11.8% on a year-over-year basis. On average, analysts anticipate that Masimo Corporation will post $2.80 EPS for the current year.
Masimo Corporation Company Profile
Masimo Corporation is a medical technology company that develops, manufactures and markets a range of non-invasive patient monitoring technologies. The Company’s business is Measure-through Motion and Low Perfusion pulse oximetry monitoring, known as Masimo Signal Extraction Technology (SET) pulse oximetry.
Receive News & Ratings for Masimo Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Masimo Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.